LY-4006895
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 07, 2026
J5K-MC-OQAA: A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
(clinicaltrials.gov)
- P1 | N=128 | Recruiting | Sponsor: Eli Lilly and Company | N=88 ➔ 128
Enrollment change • Alzheimer's Disease • CNS Disorders
December 03, 2024
J5K-MC-OQAA: A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
(clinicaltrials.gov)
- P1 | N=68 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders
1 to 2
Of
2
Go to page
1